A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe2+ under physiologically relevant conditions

被引:27
作者
Wong, Bruce X. [1 ]
Ayton, Scott [1 ]
Lam, Linh Q. [1 ]
Lei, Peng [1 ]
Adlard, Paul A. [1 ]
Bush, Ashley I. [1 ]
Duce, James A. [1 ,2 ]
机构
[1] Univ Melbourne, Oxidat Biol Unit, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia
[2] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2014年 / 1840卷 / 12期
基金
英国医学研究理事会; 欧洲研究理事会;
关键词
Ferroxidase; Ceruloplasmin; Transferrin; Iron; Oxidation; NIGRAL IRON DEPOSITION; FERROXIDASE ACTIVITY; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; HUMAN SERUM; BRAIN IRON; METAL-IONS; IN-VIVO; BINDING;
D O I
10.1016/j.bbagen.2014.08.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Iron oxidation is thought to be predominantly handled enzymatically in the body, to minimize spontaneous combustion with oxygen and to facilitate cellular iron export by loading transferrin. This process may be impaired in disease, and requires more accurate analytical assays to interrogate enzymatic- and autooxidation within a physiologically relevant environment. Method: A new triplex ferroxidase activity assay has been developed that overcomes the previous assay limitations of measuring iron oxidation at a physiologically relevant pH and salinity. Results: Revised enzymatic kinetics for ceruloplasmin (V-max approximate to 35 mu M Fe3+/min/mu M; K-m approximate to 15 mu M) are provided under physiological conditions, and inhibition by sodium azide (K-i for Ferric Gain 78.3 mu M, K-i for transferrin loading 8.1 x 10(4) mu M) is quantified. We also used this assay to characterize the non-enzymatic oxidation of iron that proceeded linearly under physiological conditions. Conclusions and general significance: These findings indicate that the requirement of an enzyme to oxidize iron may only be necessary under conditions of adverse pH or anionic strength, for example from hypoxia. In a normal physiological environment, Fe3+ incorporation into transferrin would be sufficiently enabled by the biological polyanions that are prevalent within extracellular fluids. (C) 2014 The Authors. Published by Elsevier B.V.
引用
收藏
页码:3299 / 3310
页数:12
相关论文
共 66 条
[1]   IRON TRANSPORT AND STORAGE PROTEINS [J].
AISEN, P ;
LISTOWSKY, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1980, 49 :357-393
[2]  
AISEN P, 1967, J BIOL CHEM, V242, P2484
[3]   Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease [J].
Ayton, Scott ;
Lei, Peng ;
Duce, James A. ;
Wong, Bruce X. W. ;
Sedjahtera, Amelia ;
Adlard, Paul A. ;
Bush, Ashley I. ;
Finkelstein, David I. .
ANNALS OF NEUROLOGY, 2013, 73 (04) :554-559
[4]  
BAKKER GR, 1986, J BIOL CHEM, V261, P3182
[5]   Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases [J].
Bartzokis, G ;
Tishler, TA ;
Shin, IS ;
Lu, PH ;
Cummings, JL .
REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS, 2004, 1012 :224-236
[6]   MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects [J].
Bartzokis, G ;
Cummings, JL ;
Markham, CH ;
Marmarelis, PZ ;
Treciokas, LJ ;
Tishler, TA ;
Marder, SR ;
Mintz, J .
MAGNETIC RESONANCE IMAGING, 1999, 17 (02) :213-222
[7]   In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging [J].
Bartzokis, G ;
Sultzer, D ;
Cummings, J ;
Holt, LE ;
Hance, DB ;
Henderson, VW ;
Mintz, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (01) :47-53
[8]   Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease [J].
Bharucha, Kersi J. ;
Friedman, Joyce K. ;
Vincent, Andrea S. ;
Ross, Elliott D. .
JOURNAL OF NEUROLOGY, 2008, 255 (12) :1957-1962
[9]   Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NOx content in the CSF.: A different marker profile in four neurodegenerative diseases [J].
Boll, Marie-Catherine ;
Alcaraz-Zubeldia, Mireya ;
Montes, Sergio ;
Rios, Camilo .
NEUROCHEMICAL RESEARCH, 2008, 33 (09) :1717-1723
[10]   Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease [J].
Boll, MC ;
Sotelo, J ;
Otero, E ;
Alcaraz-Zubeldia, M ;
Rios, C .
NEUROSCIENCE LETTERS, 1999, 265 (03) :155-158